<DOC>
	<DOCNO>NCT01936805</DOCNO>
	<brief_summary>The aim present study evaluate effect pre-procedural single high loading dose ( 40 mg ) rosuvastatin primary end-points cause mortality composite death myocardial infarction cardiovascular ( CV ) cause , target vessel revascularization ( TVR ) , stroke .</brief_summary>
	<brief_title>ROsuvastatin LOading Clinical Outcomes Trial</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>statinnaive patient stable ischemic heart disease de novo lesion appropriate PCI current statin use statin allergic patient acute coronary syndrome lesion appropriate PCI refusal participation statin quit follow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>